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10:00 AM–12:00 PM Pre-Congress Workshop
EVOLVING EVIDENCE AND RECOMMENDATIONS FOR THE MANAGEMENT OF OSTEOARTHRITIS OF THE
KNEE AND HIP
12:30 PM–2:00 PM Satellite Lunch Symposium
CURRENT PERSPECTIVES ON THE CLINICAL USE OF GLUCOSAMINE SULFATE AS A DISEASE MODIFYING
AGENT IN OSTEOARTHRITIS
Sponsored by Rottapharm
2:00 PM–2:15 PM WELCOME FROM PRESIDENT AND CONGRESS CHAIRS
2:15 PM–3:30 PM Plenary Session 1
2:15 PM–2:45 PM New Mechanism of Cartilage Degradation
Hideaki Nagase, PhD
2:45 PM–2:55 PM 001 AN ALTERNATIVELY SPLICED TRANSCRIPT OF ADAMTS4 IN HUMAN OSTEOARTHRITIS SYNOVIUM p. S9
S.D. Wainwright1, J. Bondeson2, C. Hughes1, B. Caterson1
1Cardiff Sch. of BioSci., Cardiff, United Kingdom; 2Dept. of Rheumatology, Cardiff University, United Kingdom
2:55 PM–3:05 PM 002 MATRIPTASE IS A NOVEL INITIATOR OF CARTILAGE MATRIX RESORPTION IN OSTEOARTHRITIS p. S9
J.M. Milner1, A. Patel1, R.K. Davidson2, T.E. Swingler2, A. Desilets3, D.A. Young1, E.B. Kelso4, S.T. Donell2,
T.E. Cawston1, I.M. Clarke2, W.R. Ferrell4, R. Plevin5, J.C. Lockhart6, R. Leduc3, A.D. Rowan1
1Newcastle Univ., Newcastle upon Tyne, United Kingdom; 2Univ. of East Anglia, Norwich, United Kingdom;
3Université de Sherbrooke, Quebec, QC, Canada; 4Royal Inﬁrmary, Glasgow, United Kingdom; 5Univ. of
Strathclyde, Glasgow, United Kingdom; 6Univ. of the West of Scotland, Paisley, United Kingdom
3:05 PM–3:15 PM 003 STIMULATION OF MMPS AND CARTILAGE DEGRADATION BY S100A8 AND S100A9 p. S10
A.E. van Hummel1,2, H. Zreiqat1, M.M. Smith2, T. Vogl3, J. Roth3, C.B. Little2
1Tissue Engineering & Biomaterials Unit, Faculty of Engineering, Univ. of Sydney, Sydney, Australia; 2Raymond
Purves Bone & Joint Res. Lab., The Kolling Inst. of Med. Res., Univ. of Sydney, Royal North Shore Hosp., Sydney,
Australia; 3Inst. of Immunology, Univ. of Muenster, Muenster, Germany
3:15 PM–3:25 PM 004 CALPAIN IS INVOLVED IN C-TERMINAL TRUNCATION OF HUMAN AGGRECAN p. S10
A. Struglics, M. Hansson
Lund Univ., Dept. of Orthopedics, Clinical Sci., Lund, Sweden
3:30 PM–4:00 PM BREAK
4:00 PM–5:15 PM Plenary Session 2
4:00 PM–4:30 PM Non Pharmalogical Clinical Trials in OA
Philippe Ravaud, MD, PhD
4:30 PM–4:40 PM 005 BENEFITS OF MASSIVE WEIGHT LOSS ON SYMPTOMS, SYSTEMIC INFLAMMATION AND CARTILAGE
TURNOVER IN OBESE PATIENTS WITH KNEE OSTEOARTHRITIS p. S10
P. Richette1, C. Poitou2, P. Garnero3, E. Vicaut1, J.-L. Bouillot4, J.-M. Lacorte2, A. Basdevant2, K. Clément2,
T. Bardin1, X. Chevalier5
1Hôpital Lariboisière, Paris, France; 2Hôpital La Pitié, Paris, France; 3Inserm 664, Lyon, France; 4Hôpital
Hotel-Dieu, Paris, France; 5Hôpital Henri-Mondor, Créteil, France
4:40 PM–4:50 PM 006 EFFECTS OF LATERAL WEDGE INSOLES ON SYMPTOMS AND STRUCTURAL DISEASE PROGRESSION IN
MEDIAL KNEE OSTEOARTHRITIS: A 12-MONTH RANDOMISED CONTROLLED TRIAL p. S11
K.L. Bennell1 , K.-A. Bowles1, C. Payne2, F.M. Cicuttini3, E. Williamson3, A. Forbes3, F. Hanna3, R.S. Hinman1
1Univ. of Melbourne, Melbourne, Australia; 2La Trobe Univ., Melbourne, Australia; 3Monash Univ., Melbourne,
Australia
4:50 PM–5:00 PM 007 INTRAARTICULAR IL1-RA AFTER ACUTE KNEE INJURY DECREASES BIOMARKERS OF INFLAMMATION AND
IMPROVES PAIN AND FUNCTION p. S11
V. Byers Kraus, J. Birmingham, T. Stabler, S. Feng, D.C. Taylor, C.T. Moorman, W.E. Garrett, A. Toth
Duke Univ., Durham, NC
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5:00 PM–5:10 PM 008 BONE MARROW LESIONS, CARTILAGE LOSS, AND PAIN IN KNEE OSTEOARTHRITIS: RESULTS FROM A
RANDOMIZED CONTROLLED CLINICAL TRIAL USINGMRI p. S12
L.M. Wildi1 , J.-P. Raynauld1, J. Martel-Pelletier1, F. Abram2, M. Dorais3, J.-P. Pelletier1
1Univ. of Montreal Hosp. Res. Ctr. (CRCHUM), Montreal, QC, Canada; 2ArthroVision Inc., Montreal, QC, Canada;
3StatSci. Inc., Notre-Dame de l’Île-Perrot, QC, Canada
5:15 PM–5:45 PM BREAK
5:45 PM–6:30 PM OPENING CEREMONY / LIFETIME ACHIEVEMENT, BASIC AND CLINICAL AWARD PRESENTATIONS
6:30 PM–6:50 PM I-01 Meta-epidemiology: Building the Bridge from Research Evidence to Clinical Practice p. S1
Weiya Zhang, MSc, PhD
6:50 PM–7:10 PM I-02 Keynote Presentation – Cartilage Inside Out p. S1
Anthony Robin Poole, PhD, DSc
7:15 PM–8:45 PM OPENING RECEPTIONWITH EXHIBITORS
Friday, September 24, 2010
7:30 AM–9:00 AM Satellite Breakfast Symposium
STRUCTURE DISEASE MODIFICATION IN OSTEOARTHRITIS: TARGETING THEWHOLE JOINT
Sponsored by Bioiberica
8:00 AM–9:00 AM Breakfast Workshop A
I-03 USINGMICROARRAYS TO INFORM LABORATORY AND CLINICAL PRACTICE p. S1
Christopher Murphy, BSc, PhD
8:00 AM–9:00 AM Breakfast Workshop B
I-04 INTRAARTICULAR THERAPIES IN THE MEDICAL MANAGEMENT OF OA p. S2
Thierry Conrozier, MD PhD
9:00 AM–10:30 AM Plenary Session 3
9:00 AM–9:30 AM Obesity and OA: From Mechanisms to Clinical Aspects
Stephen Messier, PhD
9:30 AM–9:40 AM 009 THE ASSOCIATIONOF PREVALENT CARTILAGE DAMAGE AND CARTILAGE LOSS OVER TIMEWITH INCIDENT
BONE MARROW EDEMA-LIKE LESIONS AT THE TIBIOFEMORAL COMPARTMENTS: THE MOST STUDY p. S12
M.D. Crema1,2, F.W. Roemer1,3, K. Wang1, D.T. Felson1, M.D. Marra1,4, M.C. Nevitt5 , J.A. Lynch5, J. Torner6,
C.E. Lewis7, A. Guermazi1
1Boston Univ. Sch. of Med., Boston, MA; 2Inst. of Diagnostic Imaging (IDI) and Radiology Div., Univ. of São Paulo
at Ribeirão Preto, Ribeirão Preto, Brazil; 3Klinikum Augsburg, Augsburg, Germany; 4Inst. of Diagnostic Imaging
(IDI), Ribeirão Preto, Brazil; 5Univ. of California at San Francisco, San Francisco, CA; 6Univ. of Iowa, Iowa City,
IA; 7Univ. of Alabama, Birmingham, AL
Young Investigator Award Winner
9:40 AM–9:50 AM 010 IS FOLLISTATIN-LIKE 3 OR FSTL3 NECESSARY FOR JOINT HEALTH? p. S13
B. Poulet, J. Mcneil, A.A. Pitsillides
The Royal Vet. Coll., London, United Kingdom
Young Investigator Award Winner
9:50 AM–10:00 AM 011 PROINFLAMMATORY AND CATABOLIC ROLE OF LEPTIN IN OSTEOARTHRITIS. CORRELATIONWITH IL-6,
MMP-1 ANDMMP-3 IN SYNOVIAL FLUID AND EFFECTS IN HUMAN OA CARTILAGE p. S13
A. Koskinen1 , K. Vuolteenaho1, R. Nieminen1, T. Moilanen1,2, E. Moilanen1
1The Immunopharmacology Res. Group, Med. Sch., Univ. of Tampere and Tampere Univ. Hosp., Tampere, Finland;
2Coxa Hosp. for Joint Replacement, Tampere, Finland
Young Investigator Award Winner
10:00 AM–10:10 AM 012 FUNCTIONAL CHARACTERIZATION OF OA RISK POLYMORPHISM RS225014 AT DIO2 IN HUMAN OA
CARTILAGE p. S14
S.D. Bos1,2, J. Loughlin3, R.G. Nelissen1, P.E. Slagboom1,2, I. Meulenbelt1,2
1LUMC, Leiden, Netherlands; 2Netherlands Consortium for Healthy Ageing, Leiden, Netherlands; 3Newcastle
Univ., Newcastle, United Kingdom
Young Investigator Award Winner
10:10 AM–10:20 AM 013 THE INFRAPATELLAR FAT PAD OF OSTEOARTHRITIC PATIENTS HAS AN INFLAMMATORY PHENOTYPE p. S14
I.R. Klein-Wieringa1, M. Kloppenburg1, Y.M. Bastiaansen-Jenniskens2, E. Yusuf1, J.C. Kwekkeboom1,
H. El-Bannoudi1, R.G. Nelissen1, A.-M. Zuurmond3, V. Stojanovic-Susulic4, G.J. van Osch2, R.E. Toes1,
A. Ioan-Facsinay1
1Leiden Univ. Med. Ctr., Leiden, Netherlands; 2Erasmus MC, Univ. Med. Ctr., Rotterdam, Netherlands; 3TNO
Quality of Life, Leiden, Netherlands; 4Centocor, Philadelphia, PA
Young Investigator Award Winner
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10:20 AM–10:30 AM 014 A COMPOSITE SCORE OF MULTI-JOINT RADIOGRAPHIC OSTEOARTHRITIS: THE JOHNSTON COUNTY
OSTEOARTHRITIS PROJECT p. S15
A.E. Nelson1, R.F. DeVellis1, J.B. Renner1, P.G. Conaghan2, V.B. Kraus3, J.M. Jordan1
1Univ. of North Carolina, Chapel Hill, NC; 2Univ. of Leeds, Leeds, United Kingdom; 3Duke Univ. Med. Ctr.,
Durham, NC
Young Investigator Award Winner
10:30 AM–11:00 AM OARSI Business Meeting
11:00 AM–11:30 AM BREAK
11:30 AM–12:30 PM Concurrent Session 1
ANIMAL MODELS ANDMECHANOBIOLOGY
11:30 AM–12:00 PM I-05 Post-Traumatic OA p. S2
Stefan Lohmander, MD, PhD
12:00 PM–12:10 PM 015 ACCELERATION OF OSTEOARTHRITIS PROGRESSION BY INDUCED EXPRESSION OF DISCOIDIN DOMAIN
RECEPTOR 2 IN MATURE ARTICULAR CARTILAGE OF MOUSE KNEE JOINTS p. S15
Y. Li1, I. Polur1, J.M. Servais1, S. Hsieh1, P.L. Lee1, M.B. Goldring2, L. Xu1
1Harvard Sch. of Dental Med., Boston, MA; 2The Hosp. for Special Surgery, New York City, NY
12:10 PM–12:20 PM 016 MICE OVER-EXPRESSING SALMON CALCITONIN HAVE STRONGLY ATTENUATED BONE AND CARTILAGE
CHANGES AFTER DESTABILIZATION OF THE MEDIAL MENISCUS p. S15
B.-C. Sondergaard1, C. Crüger-Hansen1, R.H. Nielsen1, T. Schinke2, A.K. Huebner2, P. Catala-Lehnen2,
M. Amling3, A.-C. Bay-Jensen1, M.A. Karsdal1
1Nordic BioSci., Herlev, Denmark; 2Univ. Sch. of Med., Inst. of Osteology and Biomechanics, Hamburg, Germany;
3Univ. Sch. of Med., Insitute of Osteology and Biomechanics, Hamburg, Germany
12:20 PM–12:30 PM 017 EFFECTS OF DYNAMIC LOADING ON INJURED ARTICULAR CARTILAGE IN VITRO AND IN VIVO p. S16
R.E. Miller1 , Y. Li1, J. Li2, A.-M. Malfait2, J. Sandy2, A. Plaas2, H.-H. Hung1, E. Frank1, A. Grodzinsky1
1MIT, Cambridge, MA; 2Rush Univ. Med. Ctr., Chicago, IL
Young Investigator Award Winner
11:30 AM–12:30 PM Concurrent Session 2
AGING AND CELL SIGNALING
11:30 AM–12:00 PM I-06 Endochondral Ossiﬁcation Signal: A Potential Therapeutic Target for Osteoarthritis p. S2
Hiroshi Kawaguchi, MD, PhD
12:00 PM–12:10 PM 018 HIF2A/NF-κB SIGNAL IN CHONDROCYTES CONTROLS EXTENSIVE STEPS OF OSTEOARTHRITIS
DEVELOPMENT IN MICE AND HUMANS p. S16
A. Fukai, T. Saito, A. Mabuchi, T. Ikeda, F. Yano, S. Ohba, N. Nishida, T. Akune, N. Yoshimura, T. Nakagawa,
K. Nakamura, K. Tokunaga, U.-i. Chung, H. Kawaguchi
The ROAD Study Group, Faculty of Med., Univ. of Toky, Tokyo, Japan
Young Investigator Award Winner
12:10 PM–12:20 PM 019 A POSITIVE ROLE OF DBC1, A SIRT1 REPRESSOR, IN THE ARTHRITIC RESPONSE IN HUMAN CHONDROCYTES p. S17
O.H. Gabay1, E. Lee1, R. Booth1, V. Gagarina1, M. Dvir-Ginzberg2, D.J. Hall1
1NIH, Bethesda, MD; 2Lab. of Cartilage Biology, Inst. of Dental Sci., Faculty of Dental Med., The Hebrew Univ.
Hadassah Ein Kerem, Jerusalem, Israel
12:20 PM–12:30 PM 020 THE EXPRESSION OF THE ANTI-APOPTOTIC TRANSCRIPTION FACTOR NF-kappaB-P65 IS MARKEDLY
DIMINISHED IN CHONDROCYTES OF MURINE OSTEOARTHRITIC CARTILAGE AND IN A SUBSET OF HUMAN
OSTEOARTHRITIC CARTILAGE SAMPLES p. S17
O.J. Arntz, M.B. Bennink, E.N. Blaney-Davidson, P.M. Kraan, W.B. van den Berg, F.A. van de Loo
Radboud Univ. Nijmegen Med. Ctr., Nijmegen, Netherlands
12:30 PM–2:00 PM Satellite Lunch Symposium
ACHIEVING EFFECTIVE OAMANAGEMENT: NEW INSIGHTS FOR CHONDROITIN SULFATE
Sponsored by IBSA
2:00 PM–3:30 PM Concurrent Session 3
IMAGING AND JOINT MORPHOMETRY
2:00 PM–2:30 PM I-07 Imaging in OA: What have we learned and where are we going? p. S3
Frank Roemer, MD
2:30 PM–2:40 PM 021 RESPONSIVENESS AND RELIABILITY OF MRI IN OSTEOARTHRITIS: ANALYTIC LITERATURE REVIEW p. S17
D.J. Hunter1, W. Zhang2, P.G. Conaghan3, K. Hirko4, L. Menashe4, W.M. Reichmann5, E. Losina5
1Univ. of Sydney, St Leonards, Australia; 2Univ. of Nottingham, Nottingham, United Kingdom; 3Univ. of Leeds,
Leeds, United Kingdom; 4New England Baptist Hosp., Boston, MA; 5Brigham and Womens Hosp., Boston, MA
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2:40 PM–2:50 PM 022 MORPHOLOGIC DIFFERENCES BETWEEN POST-TRAUMATIC OA AND PRIMARY OA KNEES - DATA FROM
THE OSTEOARTHRITIS INITIATIVE p. S18
R.B. Frobell1, M. Nevitt2, W. Wirth1, M. Hudelmaier1, J. Lee Gardiner3, D. Dreher4, F. Eckstein1
1Paracelsus Med. Univ., Salzburg, Austria; 2Univ. of California San Fransisco, San Fransisco, CA; 3Wyeth Res.,
Collegeville, PA; 4Merck Serono SA, Geneva, Switzerland
2:50 PM–3:00 PM 023 BONE SHAPE IS NOT ABNORMAL PRIOR TO OA BUT CHANGES RAPIDLY WITH OA DEVELOPMENT AND
MAY BE A USEFULMARKER OF OA OCCURRENCE p. S19
M. Bowes1, K. DeSouza1, T. Neogi2, D.T. Felson2
1Imorphics Ltd, Manchester, United Kingdom; 2Boston Univ., Boston, MA
3:00 PM–3:10 PM 024 SYNOVIAL VASCULARITY IN EARLY KNEE OSTEOARTHRITIS ASSESSED BY QUANTITATIVE
CONTRAST-ENHANCED ULTRASOUND, POWER DOPPLER ULTRASOUND AND ARTHROSCOPIC BIOPSY p. S19
M. Lintrop1, A.E. Tamm2, M. Murde3, A. Pintsaar4, L. Rips4, A. Kukner4, T. Tein4, T. Saluse4, A. Märtson4,
P. Ilves1, A.O. Tamm5
1Tartu Univ. Dept. of Radiology, Tartu, Estonia; 2Tartu Univ. Dept. of Sports Med. and Rehabilitation, Tartu,
Estonia; 3Tartu Univ. Hosp. Dept. of Pathology, Tartu, Estonia; 4Tartu Univ. Hosp. Dept. of Traumatology and
Orthopedics, Tartu, Estonia; 5Tartu Univ. Dept. of Internal Med., Tartu, Estonia
3:10 PM–3:20 PM 025 SENSITIVITY TO CHANGE OF KNEE IMAGES DIGITAL ANALYSIS COMPARED TO ALTMAN GRADING FOR
CLASSIFICATION OF RADIOGRAPHIC PROGRESSION IN EARLY OSTEOARTHRITIS (CHECK) p. S20
M.B. Kinds1,2, S.M. Bierma-Zeinstra3, A.C. Marijnissen1, M.A. Viergever2, P.M. Welsing4, F.P. Lafeber1
1Rheumatology & Clinical Immunology, Univ. Med. Ctr. Utrecht, Utrecht, Netherlands; 2Image Sci. Inst., Univ.
Med. Ctr. Utrecht, Utrecht, Netherlands; 3Gen. Practice, Erasmus Univ. Rotterdam, Rotterdam, Netherlands;
4Julius Ctr. for Hlth.Sci. & Primary Care, Univ. Med. Ctr. Utrecht, Utrecht, Netherlands
3:20 PM–3:30 PM 026 RESORPTIVE BONE REMODELING IS A PROMINENT FEATURE OF BONE MARROW LESIONS DETECTED BY
MAGNETIC RESONANCE IMAGING (MRI) IN OSTEOARTHRITIS p. S20
D. Li1, D. Wheaton2, B. Nambiar1, S. Kyostio-Moore1, E. Hutto1, P. McCree2, C. Talmo2, J. Bono2,
D. Mattingly2, D. Ward2, D.J. Hunter2, G.L. Matthews1
1Genzyme Corp., Framingham, MA; 2New England Baptist Hosp., Boston, MA
2:00 PM–3:30 PM Concurrent Session 4
CARTILAGE, LIGAMENT, TENDON AND MENISCUS BIOLOGY
2:00 PM–2:30 PM I-08 The Role of the Meniscus in Osteoarthritis Pathogenesis p. S3
Martin Englund, MD, PhD
2:30 PM–2:40 PM 027 INCREASED VASCULAR PENETRATION AND NERVE GROWTH IN THE MENISCUS: A POTENTIAL SOURCE OF
PAIN IN OSTEOARTHRITIS p. S20
S. Ashraf1, H. Wibberley1, P.I. Mapp1, R. Hill2, D. Wilson2, D.A. Walsh1,2
1Arthritis Res. UK Pain Ctr., Academic Rheumatology, City Hosp., Univ. of Nottingham, Nottingham, United
Kingdom; 2Back Pain Unit, Sherwood Forest Hosp. NHS Fndn. Trust, Mansﬁeld Road, Sutton in Ashﬁeld, United
Kingdom
2:40 PM–2:50 PM 028 INFRAPATELLAR FAT PAD FROM LATE OSTEOARTHRITIS PATIENTS HAS AN ANABOLIC PHENOTYPE p. S21
Y.M. Bastiaansen-Jenniskens1 , S.C. Clockaerts1, C. Feijt1 , M. Kloppenburg2, V. Stojanovic-Susulic3,
J. Verhaar1, A.-M. Zuurmond4, G. van Osch1
1Erasmus MC, Univ. Med. Ctr., Rotterdam, Netherlands; 2Leiden Univ. Med. Ctr., Leiden, Netherlands; 3Centocor,
Philadelphia, PA; 4TNO Quality of Life, Leiden, Netherlands
2:50 PM–3:00 PM 029 THE ANTERIOR CRUCIATE LIGAMENT IN AGING AND OSTEOARTHRITIS p. S21
S. Otsuki1,2, A. Hasegawa1, S. Pati3, S. Miyaki1, H. Asahara1, M. Kinoshita2, D. D’Lima1,3, J. Kojiol1, M. Lotz1
1The Scripps Res. Inst., La Jolla, CA; 2Osaka Med. Coll., Osaka, Japan; 3Shiley Ctr. for Orthopaedic Res. & Ed. at
Scripps Clinic, La Jolla, CA
3:00 PM–3:10 PM 030 SINGLE INTRA-ARTICULAR INJECTION RESULTS IN STABLE AND CONTROLLABLE IN VIVO TRANSGENE
EXPRESSION p. S22
K.A. Payne1, H.H. Lee1, A.M. Haleem1, C. Martin1, X. Xiao2, C.R. Chu1
1Univ. of Pittsburgh, Pittsburgh, PA; 2Univ. of North Carolina, Chapel Hill, NC
3:10 PM–3:20 PM 031 VEGF 111 AS A NEW THERAPEUTIC TOOL FOR TENDON LESION p. S22
J.-F. Kaux1, P. Drion1, V. Libertiaux1, F. Pascon1, A. Colige1, C. Le Goff1, C. Lambert1, B. Nusgens1,
A. Gothot1, S. Cescotto1, J.-O. Defraigne1, M. Rickert2, J.-M. Crielaard1
1Univ. of Liège, Liège, Belgium; 2Univ. of Heidelberg, Heidelberg, Germany
3:20 PM–3:30 PM 032 METALLOPROTEINASE EXPRESSION AND ACTIVITY IN THE MENISCUS: IMPLICATIONS FOR THE
PATHOGENESIS OF OA p. S22
E.S. Fuller, M.M. Smith, C.B. Little, J. Melrose
Kolling Inst. of Med. Res., Sydney, Australia
3:30 PM–5:00 PM POSTER SESSION 1
5:00 PM–6:30 PM Concurrent Session 5
PAIN, CLINICAL AND PATHOPHYSIOLOGICAL ASPECTS
5:00 PM–5:30 PM I-09 Dietary Supplements in OA: Real Opportunity or Utopia? p. S4
Ali Mobasheri, PhD
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5:30 PM–5:40 PM 033 EFFECTS OF FEEDING A HIGH OMEGA-3 FATTY ACID DIET ON THE PAIN-RELATED DISABILITY IN DOGS
WITH NATURALLY OCCURRING OSTEOARTHRITIS p. S23
M. Moreau, É. Troncy, D. Gauvin, B. Lussier
Université de Montréal, St-Hyacinthe, QC, Canada
5:40 PM–5:50 PM 034 CENTRAL SENSITIZATION IN KNEE OA: PRELIMINARY RESULTS FROM THE MOST STUDY p. S23
T. Neogi1, J. Niu1, L. Arendt-Nielsen2, J. Scholz3, L. Frey-Law4, C. Woolf3, Y. Zhang1, L. Bradley5, M. Nevitt6 ,
D. Felson1
1BUSM, Boston, MA; 2Univ. of Aalborg, Aalborg, Denmark; 3Childrens Hosp., Boston, MA; 4UIowa, Iowa City, MA;
5UAB, Birmingham, AL; 6UCSF, San Francisco, CA
5:50 PM–6:00 PM 035 DESTABILIZATION OF THE MEDIAL MENISCUS AS A MODEL FOR THE STUDY OF PAIN PATHWAYS
ASSOCIATEDWITH DEVELOPMENT OF MURINE OSTEOARTHRITIS p. S23
R. Das1, A. Plaas1, J.D. Sandy1, M.D. Tortorella2, A.-M. Malfait1
1Rush Univ. Med. Ctr., Chicago, IL; 2Guangzhou Inst. of BioMed. Hlth., Guangzhou, China
6:00 PM–6:10 PM 036 RUNT-RELATED TRANSCRIPTION FACTOR 2 ALLELES AND KNEE CARTILAGE LESIONS ARE ASSOCIATED
WITH INCREASES IN KNEE PAIN OVER 5 YEARS IN OLD ADULTS p. S24
C. Ding1, A. Stephens2, F. Cicuttini3, N. Morrison2, G. Jones1
1Univ. of Tasmania, Hobart, Australia; 2Griﬃth Univ. Gold Coast Campus, Gold Coast, Australia; 3Monash Univ.,
Melbourne, Australia
6:10 PM–6:20 PM 037 THE CATHEPSIN K INHIBITOR AZ12606133 REDUCES ARTICULAR CARTILAGE BREAKDOWN AND JOINT
PAIN IN OSTEOARTHRITIC KNEES p. S24
J.J. McDougall1, N. Schuelert1, J. Bowyer2
1Univ. of Calgary, Calgary, AB, Canada; 2AstraZeneca, Loughborough, United Kingdom
6:20 PM–6:30 PM 038 MMP-13 INHIBITORS REDUCE NOCICEPTION IN A RATMODEL OF OSTEOARTHRITIS p. S25
R.A. Black1, C. Gabel1, S. Lively2, M. Toteva2, P. Fan2, J. Tocker1, J. Hulme1, A. Bendele3, R. Whiteside4,
J. Henry5
1Amgen, Seattle, WA; 2Amgen, San Francisco, CA; 3Bolder BioPATH, Boulder, CO; 4Arthroteq Preclinical Services,
Toronto, ON, Canada; 5McMaster Univ., Hamilton, ON, Canada
5:00 PM–6:30 PM Concurrent Session 6
PHYSICAL THERAPY AND REHABILITATION
5:00 PM–5:30 PM I-10 Rehabilitation: From Basic Science and Biomechanics to Clinical Practice p. S4
Henning Bliddal, MD, PhD
5:30 PM–5:40 PM 039 PARTIAL JOINT IMMOBILISATION PROTECTS AGAINST OA AND REVEALS DISTINCT BIOMECHANICAL
THRESHOLDS IN THE JOINT p. S25
A. Burleigh, K. Chong, J. Saklatvala, T.L. Vincent
Kennedy Inst. of Rheumatology, London, United Kingdom
5:40 PM–5:50 PM 040 EFFECTS OF EXERCISE PROGRAM ON PAIN, JOINT STIFFNESS AND PHYSICAL FUNCTION IN ELDERLY
PATIENTS WITH KNEE OSTEOARTHRITIS. NURSING-BASED VERSUS HOME-BASED EXERCISE p. S25
M.M. Espanha1, R. Lago2, M.J. Carvalho3, A.J. Rego4, J. Teles1
1Fac. Human Kinetics-UTL, Lisboa, Portugal; 2ISAVE-Hlth.Sch. of Alto do Ave, Póvoa de Lanhoso, Portugal; 3Sports
Faculty-UP, Porto, Portugal; 4Sports Faculty, Porto, Portugal
5:50 PM–6:00 PM 041 RECENT KNEE JOINT BUCKLING IS NOT ASSOCIATEDWITH CO-ACTIVATION OF THE HAMSTRINGS DURING
ISOKINETIC QUADRICEPS ACTIVATION p. S26
N.A. Segal1, L. Frey Law1, K. Wang2, J. Torner1, C.E. Lewis3, M. Nevitt4, D. Felson2, for the Multicenter
Osteoarthritis (MOST) Study Group
1Univ. of Iowa, Iowa City, IA; 2Boston Univ., Boston, MA; 3Univ. of Alabama at Birmingham, Birmingham, AL;
4Univ. of California San Francsisco, San Francisco, CA
6:00 PM–6:10 PM 042 EFFECTIVENESS OF VIDEO-BASED HOME EXERCISE FOR OSTEOARTHRITIS OF THE KNEE: A RANDOMIZED
CONTROLLED TRIAL p. S26
H. Tohyama1, T. Chiba1, K. Tadano1, K. Ikoma1, K. Yasuda2
1Hokkaido Univ. Hosp., Sapporo, Japan; 2Hokkaido Univ. Sch. of Med., Sapporo, Japan
6:10 PM–6:20 PM 043 EFFECTS OF EXERCISE ON PROGRESSION OF OA IN KNEE JOINTS p. S27
J. Nam1, P. Perera1, J. Liu1, T. Butterﬁeld2, S. Agarwal1
1The Ohio State Univ., Columbus, OH; 2Univ. of Kentucky, Lexington, KY
Young Investigator Award Winner
6:20 PM–6:30 PM 044 A PREOPERATIVE ACTIVE REHABILITATION PROGRAM FOR PATIENTS WITH A FOCAL KNEE CARTILAGE
LESION SIGNIFICANTLY IMPROVED KNEE FUNCTION AND POSTPONED THE NEED FOR CARTILAGE REPAIR
SURGERY p. S27
M.A. Risberg1,2, J.H. Røtterud3, L. Engebretsen4, K. Bølstad5, A. Årøen4
1NAR, Norwegian Sch. Sport Sci., Oslo, Norway; 2Dept. of Orthopaedic, Oslo Univ. Hosp., Oslo, Norway;
32Orthopaedic Dept., Akershus Univ. Hosp., Akershus, Norway; 4Orthopaedic Dept., Oslo Univ. Hosp., Oslo,
Norway; 5NAR, Hjelp24NIMI, Oslo, Norway
6:30 PM–7:30 PM MEET THE PROFESSORMENTORSHIP SESSION FOR OARSI YOUNG INVESTIGATORS
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6:30 PM–8:00 PM Satellite Dinner Symposium
THE ART AND THE SCIENCE OF PAIN MANAGEMENT IN OA: INTEGRATING NEW EVIDENCE INTO CLINICAL
PRACTICE
Sponsored by Pﬁzer
Saturday, September 25, 2010
7:30 AM–9:00 AM Satellite Breakfast Symposium
PERSONALIZEDMEDICINE: NEW CHALLENGE IN OSTEOARTHRITIS
Sponsored by Bioiberica
8:00 AM–9:00 AM Breakfast Workshop C
I-11 STATISTICAL GENETIC ANALYSES OF LARGE JOINT OA p. S5
Ana Valdes, PhD
8:00 AM–9:00 AM Breakfast Workshop D
I-12 IMAGING IN HAND OA p. S5
Dennis McGonagle
9:00 AM–10:30 AM Plenary Session 4
DEBATE ON GENOME-WIDE ASSOCIATION STUDIES: WHAT DO THEY PROVIDE AND WHERE ARE WE
GOING?
9:00 AM–9:30 AM I-13 Are GWAS Studies for Osteoarthritis Worth the Expense? p. S5
Matthew Warman, MD
9:30 AM–10:00 AM I-14 Has the GWAS been Succesful? p. S5
Tim Spector, MD, MSc, FRCP
10:00 AM–10:30 AM Discussion
10:30 AM–11:00 AM BREAK
11:00 AM–12:30 PM Concurrent Session 7
EPIDEMIOLOGY AND BIOMARKERS
11:00 AM–11:30 AM I-15 Molecular Epidemiology and OA Biomarkers p. S6
P. Eline Slagboom, PhD
11:30 AM–11:40 AM 045 SUBCHONDRAL BONE TRABECULAR INTEGRITY PREDICTS AND CHANGES CONCURRENTLY WITH
OSTEOARTHRITIS PROGRESSION p. S28
K. Virginia1, S. Feng1, S. Wang1, S. White1, M. Ainslie1, M.-P. Hellio Le Graverand-Gastineau2, A. Brett3,
C. Charles1
1Duke Univ., Durham, NC; 2Pﬁzer Global Res. and Dev., Groton, CT; 3Optasia Med., Inc., Manchester, United
Kingdom
11:40 AM–11:50 AM 046 VITAMIN K DEFICIENCY IS ASSOCIATEDWITH INCIDENT KNEE OSTEARTHRITIS AND CARTILAGE LESIONS
ON MRI: THE MOST STUDY p. S28
D. Misra1, S.L. Booth2, D.T. Felson1, M.C. Nevitt3, C.E. Lewis4, J. Torner5, T. Neogi1
1BUSM, Boston, MA; 2HNRCA at Tufts Univ., Boston, MA; 3UCSF, San Francisco, CA; 4UAB, Birmingham, AL; 5Univ.
of Iowa, Iowa City, IA
11:50 AM–12:00 PM 047 USING OAI CLINICAL DATA TO STUDY THE PROGNOSTIC ROLE OF MENTAL HEALTH p. S29
D.L. Riddle1, X. Kong2, G. Fitzgerald3
1Virginia Commonwealth Univ., Richmond, VA; 2Johns Hopkins Univ., Baltimore, MD; 3Univ. of Pittsburgh,
Pittsburgh, PA
12:00 PM–12:10 PM 048 URINARYMARKERS, ALPHA CTX AND CTXII, ARE INDICATIVE OF OA SEVERITY AND BONE TURNOVER p. S29
J.L. Huebner1, A.C. Bay Jensen2, D.J. Leeming2, R.E. Coleman1, G. McDaniel1, M.A. Karsdal2, V.B. Kraus1
1Duke Univeristy Med. Ctr., Durham, NC; 2Nordic BioSci. Diagnostics, Herlev, Denmark
12:10 PM–12:20 PM 049 PROTEOMICS APPROACH FOR THE SEARCH OF OA BIOMARKERS IN SERUM p. S30
P. Fernandez-Puente1 , J. Mateos1, C. Fernandez-Costa1, N. Oreiro2, C. Fernandez-Lopez2, M. Acasuso3,
V. Bonome-Gonzalez4, C. Ruiz-Romero1, F.J. Blanco1,2
1Osteoarticular and Aging Res. Lab. Proteomic Unit-Associated Node to ProteoRed. INIBIC-Complejo Hosp. Univ.
A Coruña, A Coruña, Spain; 2Osteoarticular and Aging Res. Lab. Rheumatology Div. INIBIC-Complejo Hosp. Univ.
A Coruña, A Coruña, Spain; 3Centro de Salud San José - SERGAS, A Coruña, Spain; 4Centro Salud Matogrande -
SERGAS, A Coruña, Spain
12:20 PM–12:30 PM 050 THE IDENTIFICATION OF CIRCULATING NATURAL ANTIBODIES AGAINST ENDOGENOUS MEDIATORS IN
THE PERIPHERAL BLOOD SERA OF PATIENTS WITH OSTEOARTHRITIS OF THE KNEE: A NEW DIAGNOSTIC
FRONTIER p. S30
Y.A. Savitskaya, C. Duarte, R. Tellez, N. Marin, E. Morales, A. Izaquirre, C. Ibarra
Natl. Inst. of Rehabilitation, Mexico City, Mexico
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11:00 AM–12:30 PM Concurrent Session 8
INFLAMMATION, CYTOKINES, AND SYNOVIUM
11:00 AM–11:30 AM Antibodies Attacking Joint Cartilage
Rikard Holmdahl, MD, PhD
11:30 AM–11:40 AM 051 CONTRIBUTION OF HIGH MOBILITY GROUP BOX 1 TO SYNOVITIS IN OSTEOARTHRITIS p. S31
I. Garcia-Arnandis1 , M. Guillén1,2, F. Gomar1, J.-P. Pelletier3, J. Martel-Pelletier3, M. Alcaraz1
1Univ. of Valencia, Burjasot, Spain; 2Cardenal Herrera-CEU Univ., Moncada, Spain; 3Univ. of Montreal Hosp. Res.
Ctr. (CRCHUM), Montreal, QC, Canada
11:40 AM–11:50 AM 052 AN INCREASE IN INFLAMMATORY MARKERS IN PEOPLE WITH KNEE OSTEOARTHRITIS IS RELATED TO
PAIN AND ALTEREDWALKING PATTERN p. S31
P. Levinger1, M. Trenerry2, I. Levinger3, J. Feller1, J. Bartlett4, N. Bergman5, M. McKenna6,
D. Cameron-Smith2
1La Trobe Univ., Melbourne, Australia; 2Sch. of Exercise and Nutrition Sci., Deakin Univ., Melbourne, Australia;
3Sch. of Sport and Exercise Sci., Inst. of Sport, Exercise and Active Living, Melbourne, Australia; 4Warringal Med.
Ctr., Melbourne, Australia; 5Warringal Med. Ctr., Melbourne, Australia; 6Inst. of Sport, Exercise and Active Living,
Victoria Univ., Melbourne, Australia
11:50 AM–12:00 PM 053 SYNOVIAL INFLAMMATION IN PATIENTS UNDERGOING ARTHROSCOPIC MENISECTOMY: MOLECULAR
CHARACTERIZATION AND RELATIONSHIPWITH SYMPTOMS p. S31
C.R. Scanzello1, B. McKeon2, B. Swaim2, E. DiCarlo3, E. Umoh3, V. Kanda1, A. Nair1, D.M. Lee4,
J.C. Richmond2, M.K. Crow3, S.R. Goldring3
1Rush Univ. Med. Ctr., Chicago, IL; 2New England Baptist Hosp., Boston, MA; 3Hosp. for Special Surgery, New
York, NY; 4Brigham and Women’t Hosp., Boston, MA
12:00 PM–12:10 PM 054 THE INFRAPATELLAR FAT PAD SHOULD BE CONSIDERED AS AN ACTIVE OSTEOARTHRITIC JOINT TISSUE p. S32
S. Clockaerts1 , Y.M. Bastiaansen-Jenniskens2, G.V. Van Osch2, J.F. Van Offel1, J.A. Verhaar2, L.S. De Clerck1,
J. Somville1
1Univ. of Antwerp, Edegem, Antwerp, Belgium; 2Erasmus MC, Univ. Med. Ctr., Rotterdam, Netherlands
12:10 PM–12:20 PM 055 SYNOVIAL EXPRESSION OF CANONICAL WNT INDUCES CHONDROCYTE PHENOTYPE CHANGE AND
OA-LIKE CARTILAGE DAMAGE p. S32
A.B. Blom, P.L. van Lent, M. van den Bosch, H.M. van Beuningen, F.A. van de Loo, E.N. Blaney Davidson,
P.M. van der Kraan, W.B. van den Berg
Radboud Univ. Nijmegen Med. Ctr., Nijmegen, Netherlands
12:20 PM–12:30 PM 056 TYPE 3 FINGER LENGTH PATTERN IS ASSOCIATED WITH TOTAL KNEE (TKR) BUT NOT WITH HIP
REPLACEMENTS (THR) IN THE ELDERLY: THE AGES-REYKJAVIK STUDY p. S33
K. Sigurjonsdottir1 , T.M. Bjorgulfsson1, T. Aspelund2,1, G. Eiriksdottir2, S. Sigurdsson2, T. Ingvarsson3,
T.B. Harris4, L. Launer4, V. Gudnason2,1, H. Jonsson5
1Univ. of Iceland, Reykjavik, Iceland; 2Icelandic Heart Association, Kopavogur, Iceland; 3Central Hosp., Akureyri,
Iceland; 4Natl. Inst. on Aging, Bethesda, MD; 5Landspitalinn, Univ. of Iceland, Reykjavik, Iceland
12:30 PM–2:00 PM Satellite Lunch Symposium
FROM DISCOVERY TO THERAPEUTIC APPLICATION: THE ROLE OF CINODS IN THE MANAGEMENT OF
OSTEOARTHRITIS PATIENT
Sponsored by NiCox
2:00 PM–3:30 PM Concurrent Session 9
CARTILAGE/ BONE BIOLOGY
2:00 PM–2:30 PM I-16 Osteochondral Angiogenesis: New Therapeutic Horizons p. S6
David Walsh, PhD, FRCP
2:30 PM–2:40 PM 057 REQUIREMENT OF SYNOVIAL PERLECAN FOR OSTEOPHYTE FORMATION IN OSTEOARTHRITIS p. S33
H. Kaneko1,2, M. Ishijima1,2, I. Futami1,2, N. Ichikawa3, E. Hirasawa-Arikawa3, K. Kaneko1,2
1Dept. of Med. for Motor Organ, Juntendo Univ. Graduate Sch. of Med., Tokyo, Japan; 2Dept. of orthopedics,
Juntendo Univ. Sch. of Med., Tokyo, Japan; 3Res. Inst. for Disease of Old Age, Juntendo Univ., Graduate Sch. of
Med., Tokyo, Japan
2:40 PM–2:50 PM 058 R-SPONDINS ARE NEW PLAYERS IN OSTEOARTHRITIS THAT REGULATE WNT SIGNALING IN OSTEOBLASTS p. S33
É. Abed, T. Chan, A. Delalandre, D. Lajeunesse
CRCHUM, Hôpital Notre-Dame, Montréal, QC, Canada
2:50 PM–3:00 PM 059 GREM1, FRZB AND DKK1 ARE HIGHLY SPECIFIC MARKERS FOR ARTICULAR CARTILAGE WHICH PREVENT
HYPERTROPHIC DIFFERENTIATION p. S34
J. Leijten1, J. Emons2, C. Sticht3, E. Dekker4, G. Rappold4, C. van Blitterswijk1, J.M. Wit2, M. Karperien1
1Univ. Twente, Enschede, Netherlands; 2LUMC, Leiden, Netherlands; 3Univ. of Heidelberg, Heidelberg, Germany;
4Univ. of Heidelberg, Mannheim, Germany
3:00 PM–3:10 PM 060 MOLECULAR NETWORK ON THE C/EBP-BETA AXIS INCLUDING RUNX2, MMP13, AND HIF2A CONTROLS
OSTEOARTHRITIS DEVELOPMENT p. S34
M. Hirata1,2, F. Kugimiya1, A. Fukai1, T. Saito1, F. Yano2, T. Ikeda1, K. Nakamura1, U.-i. Chung2,
H. Kawaguchi1
1The Univ. of Tokyo, Sensory & Motor System Med., Tokyo, Japan; 2The Univ. of Tokyo, Ctr. for Disease Biology
and Integrative Med., Tokyo, Japan
Young Investigator Award Winner
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3:10 PM–3:20 PM 061 ALTERED SCLEROSTIN SYNTHESIS IN CARTILAGE AND BONE CONTRIBUTE OA PATHOLOGY p. S34
B. Chan1, E. Fuller1, L. Rowley2, D. Belluoccio2, S. Smith1, M. Cake3, R. Read3, J. Bateman2, P. Sambrook1,
C.B. Little1
1Kolling Inst. of Med. Res., Univ. of Sydney, St Leonards, Australia; 2Murdoch Childrens Res. Inst., Parkville,
Australia; 3Murdoch Univ., Perth, Australia
3:20 PM–3:30 PM 062 INDUCTION OF INFLAMMATORYMEDIATORS AND MATRIX DEGRADATION IN ARTICULAR CARTILAGE BY
TENASCIN-C AND TLR4 SIGNALING p. S35
L. Patel, W. Sun, K.E. Georgiadis, E.A. Morris, C.R. Flannery, P.S. Chockalingam
Pﬁzer, Cambridge, MA
2:00 PM–3:30 PM Concurrent Session 10
GENETICS, GENOMICS AND EPIGENETICS
2:00 PM–2:30 PM I-17 Metabolic Diseases and OA p. S6
Pascal Richette, MD, PhD
2:30 PM–2:40 PM 063 ALLELIC EXPRESSION ANALYSIS OF THE GENES WITHIN THE CHROMOSOME 7q22 OA SUSCEPTIBILITY
LOCUS REVEALS EVIDENCE FOR FUNCTIONAL POLYMORPHISM IN COG5 p. S35
A.W. Dodd, N. Wreglesworth, E.V. Raine, A. Gravani, J. Loughlin
Newcastle Univ., Newcastle upon Tyne, United Kingdom
2:40 PM–2:50 PM 064 REDUCED EXPRESSION OF COLLAGEN TYPE IX IN HUMAN OSTEOARTHRITIC CHONDROCYTES IS
ASSOCIATEDWITH EPIGENETIC SILENCING BY DNA HYPERMETHYLATION p. S36
K. Imagawa1,2, M.C. de Andrés1, K. Hashimoto3, E. Itoi2, R.O. Oreffo1, H.I. Roach1
1Univ. of Southampton, Southampton, United Kingdom; 2Tohoku Univ., Sendai, Japan; 3Hosp. for Special Surgery,
New York, NY
2:50 PM–3:00 PM 065 THE OSTEOARTHRITIS-ASSOCIATED GENE GDF5 IS UNDER EPIGENETIC REGULATION IN PATIENT TISSUES
AND IN A RANGE OF HUMAN CELL LINES p. S36
L.N. Reynard, A. Gravani, J. Loughlin
Newcastle Univ., Newcastle upon Tyne, United Kingdom
3:00 PM–3:10 PM 066 IDENTIFICATION AND CHARACTERISATION OF MICRORNAS INVOLVED IN CHONDROCYTE
DIFFERENTIATION AND OSTEOARTHRITIS p. S36
T.E. Swingler1, K.L. Culley1, F. Nicolas1, S.M. Soond1, M. Abu-Elmagd1, R.P. Boot-Handford2, D.A. Young3,
A. Chantry1, A. Munsterberg1, M. Hajihosseini1, T. Dalmay1, I.M. Clark1
1Univ. of East Anglia, Norwich, United Kingdom; 2Univ. of Manchester, Manchester, United Kingdom; 3Newcastle
Univ., Newcastle, United Kingdom
3:10 PM–3:20 PM 067 CARTILAGE-SPECIFIC MICRORNA-140 REGULATES TISSUE HOMEOSTASIS AND PROTECTS AGAINST
OSTEOARTHRITIS-LIKE PATHOLOGY p. S37
S. Miyaki1, T. Sato2, A. Inoue2, S. Otsuki1, Y. Ito2, S. Yokoyama2, Y. Kato3, S. Yamashita2, T. Nakasa2,
M.K. Lotz1, H. Kudo-Ueno2, H. Asahara1
1The Scripps Res. Inst., La jolla, CA; 2Natl. Ctr. for Child Hlth.and Dev., Tokyo, Japan; 3Natl. Inst. of Advanced Sci.
and Technology, Tsukuba, Japan
Young Investigator Award Winner
3:20 PM–3:30 PM 068 THE MICRORNAS AS BIOMARKERS SPECIFIC OF KNEE OSTEOARTHRITIS p. S37
Y.-M. Pers1,2, S. Fabre1, F. Djouad2, I. Duroux-Richard2, F. Apparailly2, D. Noel2, C. Jorgensen1,2
1Unité Thérapeutique Clinique des Maladies Ostéoarticulaires, Montpellier, France; 2INSERM U844, Montpellier,
France
3:30 PM–5:00 PM POSTER SESSION 2
5:00 PM–6:00 PM Concurrent Session 11
ADVANCES IN OA THERAPY
5:00 PM–5:30 PM I-18 Nanomedecine and Osteoarthritis: What Can We Expect for the Future? p. S7
Kazuo Yudoh, MD, PhD
5:30 PM–5:40 PM 069 STATIN USE IS ASSOCIATEDWITH REDUCED INCIDENCE AND PROGRESSION OF KNEE OSTEOARTHRITIS p. S38
S. Clockaerts1,2 , B. Stricker2, Y.M. Bastiaansen-Jenniskens2, F. Van Glabbeek1, J.B. Van Meurs2, J.A. Verhaar2,
A. Hofman2, G.V. Van Osch2, S.M. Bierma-Zeinstra2
1Univ. of Antwerp, Edegem, Antwerp, Belgium; 2Erasmus MC, Univ. Med. Ctr., Rotterdam, Netherlands
5:40 PM–5:50 PM 070 EIGHTY-SEVEN PERCENT OF 66 ADULT PATIENTS WITH ADVANCED OSTEOARTHRITIS OF THE KNEE
SUBJECTED TO TREATMENTWITH INTRA-ARTICULAR INJECTIONS OF HUMAN GROWTH HORMONE AVOID
TOTAL KNEE ARTHROPLASTY p. S38
A.R. Dunn
Mt. Sinai Med. Ctr., Miami Beach, FL
5:50 PM–6:00 PM 071 EFFECT OF ROSEMARY EXTRACT AND RELATED FLAVONOID CARNOSOL ON CHONDRO-PROTECTION AND
ON THE BONE-CARTILAGE CROSSTALK p. S38
M.-N. Horcajada1, C. Sanchez2, F. Scalfo1, L. Ameye1, Y. Henrotin2, E. Offord1
1Nestle, Lausanne, Switzerland; 2Univ. of Liège, Liège, Belgium
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5:00 PM–6:00 PM Concurrent Session 12
STEM CELLS, TISSUE ENGINEERING AND REPAIR
5:00 PM–5:30 PM I-19 Regenerative Medicine: The Biological Repair of Joint Surfaces p. S7
Frank Luyten, MD, PhD
5:30 PM–5:40 PM 072 MESENCHYMAL STEM CELLS IN OA PATIENTS: DOWNREGULATION OF WNT SIGNALING PATHWAY AND
MIR335 p. S39
B. Fernandez-Gutierrez1 , E. Villafuertes1, J. Hoyas1, M. Gonzalez2, P. Tornero-Esteban1
1Hosp. Clinico San Carlos, Madrid, Spain; 2CNIC, Madrid, Spain
5:40 PM–5:50 PM 073 MIR-7 AND MIR-130B ARE DIFFERENTIALLY REGULATED DURING MESENCHYMAL STEM CELL
COMMITMENT p. S39
G. Palmer1, L. Danielson2, M. Attur1, S.B. Abramson1, E. Hernando2
1NYUHosp. for Joint Diseases, New York, NY; 2NYU Langone Med. Ctr., New York, NY
5:50 PM–6:00 PM 074 BOVINE PRIMARY CHONDROCYTES STIMULATE CARTILAGINOUS MATRIX PRODUCTION BY HUMAN
EMBRYONIC STEM CELLS p. S39
N. Ahmed1,2, D.W. Taylor1,2, G. Keller3, M.D. Grynpas1,2, R. Kandel1,2
1Mount Sinai Hosp., Toronto, ON, Canada; 2CIHR-BioEngineering of Skeletal Tissues Team, Toronto, ON, Canada;
3McEwen Ctr. for Regenerative Med., Univ. Hlth.Network, Univ. of Toronto, Toronto, ON, Canada
6:00 PM–7:30 PM Satellite Dinner Symposium
EXPLORING EMERGING CONCEPTS IN OSTEOARTHRITIS: PATHOGENESIS, BIOMARKERS AND FUTURE
THERAPIES
Sponsored by Novartis
7:30 PM–10:30 PM CONGRESS DINNER
Sunday, September 26, 2010
8:00 AM–9:00 AM Breakfast Workshop E
I-20 IMPACT OF OSTEOARTHRITIS PAIN ON THE BRAIN p. S7
A. Vania Apkarian, PhD
Thomas Schnitzer, MD, PhD
8:00 AM–9:00 AM Breakfast Workshop F
I-21 IMAGING FOR MEASUREMENT OF DYNAMIC JOINT FUNCTION p. S8
Scott Tashman, PhD
9:10 AM–10:30 AM Concurrent Session 13
SURGICAL TREATMENT
9:10 AM–9:40 AM Optimizing Outcomes in Total Joint Replacement Surgery
Göran Garellick, MD, PhD
9:40 AM–9:50 AM 075 OSTEOARTHRITIS PATIENTS’ PERCEPTIONS REGARDING APPROPRIATENESS FOR TOTAL JOINT
REPLACEMENT SURGERY p. S40
G. Hawker1, L. Frankel1, L. Freeman-Collins2, D. Marshall3, B. Conner-Spady3, C. SanMartin4
1Univ. of Toronto, Toronto, ON, Canada; 2Women’s Coll. Hosp., Toronto, ON, Canada; 3Univ. of Calgary, Calgary,
AB, Canada; 4Statistics Canada, Ottawa, ON, Canada
9:50 AM–10:00 AM 076 FOURTEEN YEAR RISK OF REVISION FOLLOWING PRIMARY TOTAL HIP REPLACEMENT PERFORMED IN A
US POPULATION BASED SAMPLE p. S40
J.N. Katz1,2, E.A. Wright1,2, A.A. Nti1, J. Wright1,2, E. Losina1,2
1Brigham and Women’s Hosp., Boston, MA; 2Harvard Med. Sch., Boston, MA
10:00 AM–10:10 AM 077 THE USE AND OUTCOME OF HIGH TIBIAL OSTEOTOMY FOR KNEE OSTEOARTHRITIS IN SWEDEN 1998-2007 p. S41
A. W-Dahl, O. Robertsson, S. Lohmander
Clinical Sci., Lund, Lund, Sweden
10:10 AM–10:20 AM 078 JOINT DISTRACTION IN TREATMENT OF CANINE EXPERIMENTALLY INDUCED OSTEOARTHRITIS LEADS TO
CARTILAGE REPAIR ACCOMPANIED BY SUSTAINED RELIEVE OF PAIN p. S41
S.C. Mastbergen1, F. Intema1, P.M. van Roermund2, H.A. Hazewinkel3, F.P. Lafeber1
1Rheumatology & Clinical Immunology, Univ. Med. Ctr. Utrecht, Utrecht, Netherlands; 2Orthopaedics, Univ. Med.
Ctr. Utrecht, Utrecht, Netherlands; 3Vet. Med., Utrecht Univ., Utrecht, Netherlands
10:20 AM–10:30 AM 079 RECOVERY FOLLOWING TOTAL HIP AND KNEE REPLACEMENT: THE INTERPLAY OF PHYSICAL
IMPAIRMENTS, ACTIVITY LIMITATIONS AND PARTICIPATION RESTRICTIONS p. S41
A.M. Davis1, E.M. Badley1, S. Hogg-Johnson2, S. Ibrahim2, A.V. Perruccio3, R. Wong1, D.E. Beaton4, P. Côté1,
M.A. Gignac1, D. Streiner5
1Toronto Western Res. Inst., Toronto, ON, Canada; 2Inst. for Work and Hlth., Toronto, ON, Canada; 3Harvard and
Brigham and Women’s Hosp., Boston, MA; 4St. Michael’s Hosp., Toronto, ON, Canada; 5Kunin-Lunenfeld Res.
Inst., Baycrest Hosp., Toronto, ON, Canada
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9:10 AM–10:30 AM Concurrent Session 14
SPINE AND INTERVERTEBRAL DISC
9:10 AM–9:40 AM I-22 Links between Intervertebral Disc Degeneration and Osteoarthritis p. S8
Jill Urban, PhD
9:40 AM–9:50 AM 080 LUMBAR DISC DEGENERATION AND GENETIC FACTORS ARE THE MAIN RISK FACTORS FOR LOW BACK
PAIN: THE UK TWIN SPINE STUDY p. S42
G. Livshits1,2, S. Ermakov2, M. Popham1, A.J. MacGregor1,3, P.N. Sambrook4, T.D. Spector1, F.M. Williams1
1King’s Coll. London, London, United Kingdom; 2Sackler Faculty of Med., Tel Aviv University, Israel; 3Sch. of Med.,
University of East Anglia, United Kingdom; 4Inst. of Bone and Joint Res., University of Sydney, Australia
9:50 AM–10:00 AM 081 DISC DEGENERATION OF THE UPPER LUMBAR DISCS IS ASSOCIATEDWITH HIP PAIN p. S42
E. de Schepper, J. Damen, A. Hofman, B. Koes, S. Bierma-Zeinstra
Erasmus MC, Rotterdam, Netherlands
10:00 AM–10:10 AM 082 SPINE OSTEOARTHRITIS DOES NOT PROTECT AGAINST INCIDENT VERTEBRAL FRACTURES DESPITE
HIGHER LUMBAR SPINE BMD p. S43
M.C. Castaño Betancourt, F. Rivadeneira, A. Hofman, S. Bierma-Zeinstra, H. Pols, A.G. Uitterlinden, J. Van
Meurs
Erasmus MC, Rotterdam, Netherlands
10:10 AM–10:20 AM 083 LASER-INDUCED DISC DEGENERATION: A NEW ANIMAL MODEL TO EVALUATE TISSUE ENGINEERING
STRATEGIES p. S43
O. Lucas1,2, J. Clouet1, O. Hamel1,3, M. Fusellier4, B. Fellah4, O. Gauthier4, J. Lesoeur1, Y. Cherel5,
G. Grimandi1, E. Bord6, P. Weiss1, C. Vinatier1, J. Guicheux1
1Inserm U791 - LIOAD, Nantes, France; 2Neurosurgery Dept. - Univ. Hosp., Nantes, France; 3Neurosurgery Dept. -
Univ.ry Hosp., Nantes, France; 4Preclinical animal research centre - Natl. Vet. Sch., Nantes, France; 5INRA
UMR703 - Natl. Vet. Sch., Nantes, France; 6Neurosurgery Dept. - Univ.ry Hosp., Nantes, France
10:20 AM–10:30 AM 084 MCMASTER-TORONTO ARTHRITIS PATIENT PREFERENCE DISABILITY QUESTIONNAIRE (MACTAR)
SENSITIVITY TO CHANGE IN DISABLING CHRONIC LOW BACK PAIN: INFLUENCE OF SHIFTS IN PATIENTS
PRIORITIES OVER TIME p. S43
K. Sanchez, A. Papelard, C. Nguyen, F. Rannou, M. Revel, S. Poiraudeau
AP-HP, Université ParisDescartes, Paris, France
10:30 AM–11:00 AM BREAK
11:00 AM–12:30 PM Plenary Session 5
OA YEAR IN REVIEW
Etiopathogenesis




Virginia Byers Kraus, MD, PhD
Imaging
David Hunter, MBBS, PhD, FRACP
Pharmacology
Francis Berenbaum, MD, PhD
Non-Pharmacology
Gillian Hawker, MD, PhD
